1. Home
  2. CRBU vs TBI Comparison

CRBU vs TBI Comparison

Compare CRBU & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • TBI
  • Stock Information
  • Founded
  • CRBU 2011
  • TBI 1985
  • Country
  • CRBU United States
  • TBI United States
  • Employees
  • CRBU N/A
  • TBI N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • TBI Professional Services
  • Sector
  • CRBU Health Care
  • TBI Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • TBI Nasdaq
  • Market Cap
  • CRBU 236.3M
  • TBI 255.1M
  • IPO Year
  • CRBU 2021
  • TBI 1996
  • Fundamental
  • Price
  • CRBU $1.79
  • TBI $8.35
  • Analyst Decision
  • CRBU Strong Buy
  • TBI Buy
  • Analyst Count
  • CRBU 4
  • TBI 2
  • Target Price
  • CRBU $12.00
  • TBI $11.50
  • AVG Volume (30 Days)
  • CRBU 1.5M
  • TBI 205.8K
  • Earning Date
  • CRBU 11-06-2024
  • TBI 11-04-2024
  • Dividend Yield
  • CRBU N/A
  • TBI N/A
  • EPS Growth
  • CRBU N/A
  • TBI N/A
  • EPS
  • CRBU N/A
  • TBI N/A
  • Revenue
  • CRBU $11,475,000.00
  • TBI $1,673,611,000.00
  • Revenue This Year
  • CRBU N/A
  • TBI N/A
  • Revenue Next Year
  • CRBU N/A
  • TBI N/A
  • P/E Ratio
  • CRBU N/A
  • TBI N/A
  • Revenue Growth
  • CRBU N/A
  • TBI N/A
  • 52 Week Low
  • CRBU $1.50
  • TBI $6.63
  • 52 Week High
  • CRBU $8.33
  • TBI $15.93
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 37.96
  • TBI 56.75
  • Support Level
  • CRBU $1.72
  • TBI $8.18
  • Resistance Level
  • CRBU $1.97
  • TBI $9.05
  • Average True Range (ATR)
  • CRBU 0.14
  • TBI 0.35
  • MACD
  • CRBU -0.03
  • TBI 0.00
  • Stochastic Oscillator
  • CRBU 9.12
  • TBI 56.69

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.

Share on Social Networks: